Esculon, Inc.

Amendment

CIK: 0001709643·Biotechnology·DELAWARE·Filed: Nov 27, 2017

Total Offering

$2,925,826

Amount Sold

$2,925,826

Investors

14

First Sale

Jun 7, 2017

Offering Details

Type: Equity
Exemptions: Rule 506(b)
Entity Type: Corporation
Year Incorporated: 2016
Non-Accredited Investors: No

Related Persons

Name	Role
Evan Luxon	Related Person
ALAN CHESLER	Related Person
Carter Meyer	Related Person
Danial Burnett	Related Person
Deepak Gangahar	Related Person

Company

3929 Harney Street

OMAHA, NE, 68198

402-417-0740

SEC Filing

0001709643-17-000003

View on SEC EDGAR

Want deeper insights?

Sign up for free to search all filings, track companies, and set up alerts.